Answers are grounded in this paper and cite their sources.
Although Aβ1-42 and Aβ1-42/Aβ1-40 are considered markers of the same pathophysiological pathway, our findings provide evidence favoring the use of the Aβ1-42/Aβ1-40 ratio in clinical laboratories in the context of AD.
No takes yet. Share an insight, caveat, or question.
Delaby et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: